OGA and endometrial cancer: Analysis of gene alterations of OGT and OGA (OGT and MGEA5, respectively) using data from the RNAseq and Microarray databases available in cBioPortal (http://cbioportal.org) revealed that of the 18 female reproductive cancer databases available, Uterine/Endometrial Cancer ranks highest for gene alterations to OGT and MGEA5, including both mutational and amplification modifications (Figure 1A).